Close Menu
    What's Hot

    Morrisons Retirement Saver Plan Completes Bulk Purchase Annuity Buy-In With Aviva

    28 May 2025

    Yellow Pages Limited Purchases Group Annuity Contracts From BMO Life Assurance Company

    22 May 2025

    Life ILS Conference 2025

    20 May 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy

      14 May 2025

      Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles

      14 May 2025

      Is Servicing an Overlooked Source of Life Settlement Alpha?

      14 May 2025

      Q&A: Shelly Beard, Managing Director, WTW

      14 May 2025

      Longevity Tech to Emerge as Distinct Sub-Sector of Venture Capital Market?

      14 May 2025
    • Commentary

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025

      The Power of Uncorrelated Diversification During Market Volatility

      14 May 2025

      Overseeing BPA Growth Safely

      14 May 2025

      Could Climate Change Cause the Buy-In Market To Collapse?

      10 April 2025

      ICS vs Solvency II: Comparing Risk Corrections for Illiquid Liabilities

      10 April 2025
    • Events
    • Magazine
    • News

      Morrisons Retirement Saver Plan Completes Bulk Purchase Annuity Buy-In With Aviva

      28 May 2025

      Yellow Pages Limited Purchases Group Annuity Contracts From BMO Life Assurance Company

      22 May 2025

      Andrew Limited Pension and Life Assurance Plan Completes Bulk Annuity Transaction With Aviva

      15 May 2025

      Life Insurance Settlement Association Publishes Latest Market Data Collection Survey Results

      13 May 2025

      UK Aggregate Defined Benefit Pension Fund Surplus Down Again in April

      12 May 2025
    Subscribe
    Life Risk News
    Home » Q&A: Nicola Oliver, Medical Intelligence

    Q&A: Nicola Oliver, Medical Intelligence

    Features 14 February 2024Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    The past few years have been arguably the most significant ever to those studying longevity and mortality, with a range of issues impacting the field, and consequently, actuaries and risk holders. Greg Winterton spoke to Nicola Oliver, Director of Life and Health at consulting firm Medical Intelligence, to get her thoughts on the current state of the space. 

    GW: Nicola, you advise actuaries and companies about the impact of the provision of healthcare on longevity and mortality. So, let’s start with Covid-19. What are some of the hangovers in terms of the provision of healthcare that the industry is still reeling from? 

    NO: Healthcare provision in the UK, for example, was already under strain even before the onset of the pandemic which made the impact of the pandemic so much worse. This was driven by declining bed stock, staff shortages, and lengthening waiting times.   

    A lack of system capacity meant all but the most urgent of non-Covid care had to be cancelled, including many cancer treatments. 

    As a consequence, there was no robust built-in preparedness; indeed, many clinical areas were running at close to or even over 100% capacity prior to the pandemic.  

    If we look at waiting lists, which serve as good barometer for how well the NHS is coping with workload, analysis by the Health Foundation shows that the waiting list for routine hospital treatment (‘elective care’) in England could rise to over eight million by mid-2024 regardless of whether NHS industrial action continues. 

    The knock-on effect from this alone could mean delayed identification of chronic diseases that rely on timely diagnosis to ensure an optimum outcome such as cancer and heart disease. This could mean more advanced disease at diagnosis leading to increased mortality rates at younger ages, an increase in premature mortality is possible.  

    GW: There has been coverage in the news media in recent weeks and months about the persistence of excess deaths. What are some of the drivers of this and are these short, medium or long-term issues? 

    NO: The drivers for persistent excess mortality are indeed multiple and complex to disentangle. As mentioned above, it is likely that some of it is driven by the immense pressure on the NHS, as well as the ongoing impact of Covid. Deaths from cardiovascular causes show a relative excess greater than that seen in deaths from all-causes. This could be as a result of both NHS pressures and the direct effect of Covid. It is known that the virus responsible for Covid is able to damage the cells of the heart and blood vessels.  

    The impact of both NHS pressures and Covid are likely to play out into the long-term. 

    GW: You wrote a guest article last year for Life Risk News where you analysed the impact of climate change on mortality. Have you seen any increase in how actuaries consider this issue when modelling mortality, or is it still one where not enough folks are paying attention to it? 

    NO: I think that awareness is increasing; and this is being translated into action, albeit gradually. The message needs to keep being sent; we’re seeing climate change in action here in the UK, there is really no excuse for a head-in-the-sand approach any longer. 

    GW: The recent – maybe even ongoing – cost of living crisis is also very relevant to the provision of healthcare. Is consumer finance and debt currently having a significant impact on mortality or is it less of an issue than others? 

    NO: The effects of recessions on health differ across different health conditions, as well as by mortality and morbidity. There is also the time frame to consider; short-term events seem to have a positive impact on health on a population wide scale, whereas longer-term recessions are shown to be negative. There is no doubt, however, that psychological and physical health are affected by debt as well as by increased financial concern. These impacts are clearly socioeconomically driven. Those in poorer circumstances do not have wealth resilience and will suffer the most. 

    GW: Lastly, Nicola, at a previous Life ILS Conference, you discussed developments in wearable technology in the health space. Is that still an exciting area in terms of how it could impact the public health arena, or has it plateaued at all? 

    NO: Yes, I would say this is still an exciting area, particularly when partnered with big data analytics. Wearables not only encompass those devices which we traditionally think about as being associated with this area, such as fitness trackers and specific clinical devices such as continuous glucose monitors, but also the humble smartphone. Complementary metal-oxide-semiconductor (CMOS) image sensors that are in smartphones may be used to monitor heart, eye, and skin-related diseases. Heart rhythm disorders can be identified and even symptoms of Parkinson’s disease.  

    Nicola Oliver is Director of Life and Health at Medical Intelligence 

    2024 - February Longevity and Mortality Trends Q&A Volume 3 Issue 2 - February 2024
    Share. Twitter LinkedIn Email

    Related Posts

    New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy

    14 May 2025

    Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles

    14 May 2025

    Is Servicing an Overlooked Source of Life Settlement Alpha?

    14 May 2025

    Q&A: Shelly Beard, Managing Director, WTW

    14 May 2025

    Comments are closed.

    Most Popular

    New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy

    14 May 2025

    Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles

    14 May 2025

    Is Servicing an Overlooked Source of Life Settlement Alpha?

    14 May 2025

    UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

    14 May 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT